Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.43 |
| ▸ | NPY1R | P25929 | 7/20 | 0.43 |
| ▸ | NPY2R | P49146 | 5/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.43 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30213322 | 0.92 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RF2RL1 | |
| SCHEMBL29678410 | 0.91 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RF2RL1 | |
| SCHEMBL31415951 | 0.91 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| SCHEMBL29436278 | 0.89 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL29436277 | 0.89 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31670471 | 0.89 | RXFP1 (0.46) | NPY4RNPY1RNPY2RNPY5RRXFP1 | |
| SCHEMBL30121216 | 0.89 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RF2RL1 | |
| SCHEMBL29678534 | 0.88 | ENPEP (0.39) | RXFP1NOD1ENPEP | |
| SCHEMBL6941592 | 0.87 | NPY4R (0.43) | NPY4RNPY1RNPY2RNPY5RRXFP1 | |
| SCHEMBL29678646 | 0.87 | ENPEP (0.38) | RXFP1NOD1ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | F2RL1, F2R, F2RL3 | NPY4R 450/4885NPY1R 296/4885NPY2R 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.